Atherosclerosis and Non-Alcoholic Fatty Liver Disease

Area of Science:

• Hepatology and Cardiovascular Medicine

Background:

• Non-alcoholic fatty liver disease (NAFLD) is characterized by excessive fat accumulation in the liver.
• Pathogenic mechanisms include insulin resistance, obesity, and dysregulated fatty acid metabolism, potentially leading to steatosis and non-alcoholic steatohepatitis (NASH).

Purpose of the Study:

• To review the intricate relationship between NAFLD and atherosclerosis.
• To elucidate how NAFLD impacts lipid-glucose metabolism, hypertension, and systemic inflammation.

Main Methods:

• This review synthesizes findings from numerous clinical studies examining NAFLD and its cardiovascular implications.
• Analysis focuses on the pathogenic pathways connecting liver fat to systemic vascular disease.

Main Results:

• NAFLD is strongly associated with atherosclerosis, a condition involving the hardening of arteries.
• NAFLD can disrupt lipid and glucose metabolism, elevate blood pressure, and promote systemic inflammation.
• These metabolic and inflammatory changes significantly increase the risk of vascular events.

Conclusions:

• NAFLD is a critical factor in the development of atherosclerosis.
• Understanding the link between NAFLD and cardiovascular disease is essential for risk stratification and management.